A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

计划入组 5,815 人 · 首次发布于 2019 年 6 月 11 日

A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants

计划入组 2,192 人 · 首次发布于 2022 年 2 月 16 日

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

计划入组 21 人 · 首次发布于 2008 年 3 月 10 日

Nirsevimab(Beyfortus)

Rx

undisclosed respiratory program (respiratory disease)

undisclosed respiratory disease program (respiratory diseases)

TRACT Therapeutics, Inc.

United States

RSV Therapeutics LLC

The Lower Valley Hospital Association

United States

MSD's Clesrovimab Shows Promise in RSV Prevention, Eyes 2025 Launch

RSV Vaccines Face Uptake Challenges Despite FDA Approval for Older Adults

Sanofi Ships Beyfortus in US to Protect Infants Against RSV